ANDiS SARS-CoV-2 RT-qPCR Detection Kit ANDiS SARS-CoV-2 and Influenza A/B RT-qPCR Detection Kit ANDiS 350 Automated Nucleic Acid Extraction System
Molecular Diagnostic / RT-PCR Quality Control Kit Cobas Liat SARS-CoV-2 and Influenza A / B Positive Level / Negative Level 3 X 0.25 mL / 3 X 10 µL / 3 X 0.3 mL UOM: 1/KT Product Number: 09211128190 Manufacturer: Roche
Reagent Cobas Liat Nucleic Acid Test Influenza A / B, Respiratory Syncytial Virus (RSV) For Cobas Liat Automated PCR Analyzer 20 Tests 20 Tubes UOM: 20/CS Product Number: 08160104190 Manufacturer: Roche
Authorized reseller of Access Bio & Celltrion Rapid COVID-19 Antigen Tests (2 Pack). Please contact for more details whether one time buy or contract orders.
Official Sales Partner for Master Distributor of iHealth Rapid Test NOT A BROKER OR RE-SELLER AVAILABLE FOR IMMEDIATE DELIVERY IN THE USA FDA AUTHORIZED 15 MINS SELF-TEST Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $9 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8 *Prices subject to change without notice
CareStarfTM COVID-19 ANTIGEN RAPID TESTS Why CareStartTM COVID-19 Live infection 10 minutes Diagnostic Tests dose not require a machine reader! Abbott, Quidel, and BD require readers, that are in short supply. â?¢ EASY TO USE CareStart â?¢ AVAILABILE Rapid Tests on the shelf available products (in inventory) with We offer CareStartTM reliable production and delivery schedules. Abbott, Quidel and BD testing cassettes are in short supply with unreliable availability. â?¢ FDA EUA is currently the only Point-Of-Care rapid antigen test registered authorized under the FDA EUA. CareStart TM CareStarfTM COVID-19 ANTIGEN RAPID TESTS Features Identify individual's current infection status to COVID-19 Fast and easy to use in Point-of-Care setting Qualitatively detect the SARS-CoV-2 nucleocapsid protein Use nasopharyngeal (NP) swab specimens Reliable results only in 1O minutes No special equipment or training required All-in-one package including collection swabs High sensitivity (88.4�°/o) and specificity (100�°/o) Kit Components 20 test devices 20 extraction vials and caps 20 NP swabs 1 positive and 1 negative controls Package insert Quick reference Instructions (QRI)
We can provide Covid-19 Rapid Antigen Test. Test with reliable results within minutes. Made in the USA. Lateral flow assay, No equipment required, Results within 10 minutes, minimally invasive specimen collection, nasal swab, POC (in patient care setting). Detects SARS-CoV2 nucleocapsid protein antigen with ultra high performance. Identifies acute infection with 88.4% sensitivity and 100% specificity. Complies with FDA. Principals or Buyer's Mandates only. No broker chains. FOB or CIF. Minimum order 500000 test please.
10,000 Rapid Antigen Test 500 Boxes 20 Test Per Box CE CERTIFICATION
Lateral flow assay No equipment required Rapid results within 10 minutes Minimally invasive specimen collection (nasopharyngeal swabs) POC setting (i.e. in patient care settings) by medical professionals Detects SARS-CoV-2 nucleocapsid protein antigen with ultra high performance Identify acute infection wit 88.4% sensitive and 100% specificity 20 test/box 20 test devices 20 assay buffer 20 extraction vials and caps 20 specifimen collection swabs 1 positive and 1 negative control swabs 1 instructions for use
Made in Canada Health Canada approved CE Mark and ISO certified The product has proven to have 100% Specificity and 96% Sensitivety Stock availabity: 2 Million tests/kit in Canada Production: up to 5 Million tests/kit weekly The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only. PRODUCT INFORMATION: Product: Rapid Respose Sample: Nasal / Nasopharyngeal secretions Format: Cassette Quantity: 25 Tests/Kit per box Time to result: 15 minutes Storage Condition: 2-30 C/36-86 F Test Principle: Immunochromatographic Assay CONTENTS - Individually packed test devices Extraction Buffer Extraction tube Nozzle with filter Tube stand Individually packed swabs Package Insert
HPV 16 & 18, And Other 12 Types FDA CE Approved
Rapid Antigen Covid-19Test Kits 200 million boxes - $3 per test Health Canada, IVD, TUV, CE certification Product Information: Quantity: 20 tests/kit Sample type: Nasopharyngeal swab Storage temperature: 2-30°C The most accurate rapid antigen tests worldwide and provide results in 10 minutes. Test time: 10-15 minutes Rapid 2019-nCoV IgG/IgM Combo Test is a rapid immunochromatographic assay for the simultaneous detection of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma, or whole blood. Kit Contains: 20 Rapid SARS-CoV-2 Antigen Test Cards (Individually packaged) 2 Sample Buffers 20 Sterilized swabs (Individually packaged) 20 Extraction tubes (Individually packaged) 1 Instructions for use 1 Tube rack (for 6 tubes/rack)
Everything needed to run a test with materials provided in each kit: 20 Rapid SARS-CoV-2 Antigen Test Cards (Individually packaged) 2 Sample Buffer 20 Sterilized swabs (Individually packaged) 20 Extraction tubes (Individually packaged) 1 Instruction for use 1 Tube rack (for 6 tubes/rack) Product Information: Quantity: 20 tests/kit Sample type: Nasopharyngeal swab Storage temperature: 2-30 C Shelf life: 18 months Test time: 15-20 minutes Intended Use: This product is authorized and intended for use by trained laboratory or healthcare professionals for in vitro diagnostic use. Point-of-care professionals administering tests are required to report all results to the appropriate public health authorities. Note: Consult your provincial and local health care authorities for POC guidelines for rapid testing use.
After the virus infection, the antibody IgM appears and rises in the early stage, while antibody IgG appears and rises in the late stage. â?¢ By combining IgG and IgM, we can know if the body is infected and at which stage . the Kit inckude: Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit (Colloidal Gold) â?¢ Transport or store at room temperature from 2 to 30°C â?¢ If individual pouch unopened, the kit can be stored for 12 months. â?¢ Once the individual pouch is opened, this test card should be used within 1 hour.
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
Highest accuracy Fast result interpretation Cost effective Made with best choices of materials Type: immunoassay system Brand name: ntbio/oem/private label Place of origin: british columbia, canada Size: 60mm x 300mm Accuracy: 99.9% Sensitivity: 20 miu/ml Specimen: urine .
Blood sample size: 1-2 µL; if sample applied at the center of test pad. Sample type: Capillary, Venous, Arterial, Neonatal. Sample dosing: Large test pad for top dosing suitable for AST options. Compatibility: Only with AC Active meter. Storage: +2C to 30C. Quality control: 2 levels - 50 mg/dL and 150 mg/dL. Strip Stability: 18 months
New Sealed in Box FreeStyle Lite 50ct Test Strips Expire 02/2024
New Sealed in Box FreeStyle Lite 100ct Test Strips Expire 02/2024
New Sealed in Box OneTouch Ultra Blue 50ct Test Strips Expiration: 10/2023
